Clasp Therapeutics Launches with $150 Million Investment in Pioneering Precision Immuno-oncology Startups
‘Junk DNA’ No More: Johns Hopkins Investigators Develop Method of Identifying Cancers from Repeat Elements of Genetic Code Technologies
Biolinco, Stem Equity Project, TiBi, and Whisper Win the Judge's Prize at FastForward U Spark Showcase Pava Center
